GLP-1 Oracle
Providers Coverage Costs Reference
Compare providers

51/51 states verified · 25/25 providers audited

United States The coverage and price record

What Zepbound and Wegovy cost, and who covers them.

Lilly and Novo Nordisk sell direct. A dozen telehealth companies sell a membership with the medication priced on top. And 14 of the 51 state Medicaid programs we have read cover them for weight loss. Every figure links to the document it came from.

Read from 51 Medicaid drug lists, each one linked and dated. Last checked August 28, 2026

Compare what providers charge Check your insurer

We publish information. We do not prescribe, we do not sell medication, and nothing here is medical advice.

Where the record stands

September 6, 2026
51/51
states verified
51 of 51
25/25
providers audited
25 of 25
3
drugs tracked
6
reference only

Anything we have not checked renders as not checked , never as a guess. Somebody makes a $500-a-month decision on these rows.

25

Audit example: Alloy

LegitScript Yes
Price up front Yes
Cancel online Yes

Providers, audited

Every directory in this category ranks providers. We check them: LegitScript status, which pharmacy dispenses, whether the price shows before the intake form, and whether you can cancel without a phone call.

See the audit
51

Medicaid weight-loss coverage

AL Other indications only Alabama
AK Other indications only Alaska
AZ Not covered Arizona

states, one grid

14 of the 51 programs we have read cover GLP-1s for weight loss. We read the formulary, link to it, and mark what we have not read.

Open the grid
13

What goes into the price

Medication
Care, if billed separately
Other fees, if any
The full cost

Cash routes, priced

Manufacturer direct, telehealth membership, savings card, or cash at the counter. Every route priced, re-checked quarterly, with the source next to the number.

See the prices

United States The grid, at a glance

Fifty-one programs. One square each.

Every state runs its own Medicaid program and reaches its own answer. A square is filled once somebody here has opened that state's own drug list and read it, and it stays hatched until then.

The color is the best route we found in that state, across all three medicines.

Alaska: Other indications only Maine: Other indications only Vermont: Other indications only New Hampshire: Other indications only Washington: Other indications only Idaho: Not covered Montana: Not covered North Dakota: Other indications only Minnesota: Covered, prior authorization Wisconsin: Covered, prior authorization Michigan: Covered, prior authorization New York: Not covered Massachusetts: Other indications only Rhode Island: Covered, prior authorization Oregon: Other indications only Nevada: Other indications only Wyoming: Other indications only South Dakota: Not covered Iowa: Other indications only Illinois: Not checked Indiana: Covered, prior authorization Ohio: Other indications only Pennsylvania: Other indications only New Jersey: Other indications only Connecticut: Not checked California: Other indications only Utah: Other indications only Colorado: Other indications only Nebraska: Other indications only Missouri: Covered, prior authorization Kentucky: Other indications only West Virginia: Other indications only Virginia: Covered, prior authorization Maryland: Other indications only Delaware: Covered, prior authorization Arizona: Not covered New Mexico: Not covered Kansas: Covered, prior authorization Arkansas: Not covered Tennessee: Covered, prior authorization North Carolina: Covered, prior authorization South Carolina: Not covered District of Columbia: Not covered Oklahoma: Not covered Louisiana: Not checked Mississippi: Covered, prior authorization Alabama: Other indications only Georgia: Covered, prior authorization Hawaii: Covered, prior authorization Texas: Other indications only Florida: Not covered
Covered, prior authorization Other indications only Not covered Read, and it did not say

The difference

Eleven directories rank providers. None of them verify one.

A ranked list is easy to write and worth nothing, because the thing a reader actually needs to know is whether the company is what it says it is. So the audit is the product. Five checks, on the provider's own pages, on a stated date.

Where a check has not been done, the row says so. It never says "yes" because the provider's marketing said so.

An example from the record

Alloy

Checked August 30, 2026

  1. 01

    Dispensing pharmacy

    none published

    Who physically fills it, whether they compound it or dispense a manufactured product, and whether they are licensed to. It decides what is legally in the vial.

  2. 02

    LegitScript certified

    Yes

    Certified or not, on the date we looked. It is the certification the ad platforms themselves check before they will run a healthcare advertiser.

  3. 03

    Price shown before intake

    Yes

    Whether the full monthly price is visible before you hand over a medical history, or only after.

  4. 04

    Cancel online

    Yes

    Whether you can stop a recurring charge yourself, or have to call during business hours to do it. No federal rule requires the easy version: the one that would have was struck down in 2025.

  5. 05

    Prescriber disclosed

    Yes

    Whether the clinician writing the prescription is named, or at least their licensing state is stated. A prescriber has to hold a license in the state you are physically in at the time of the consultation.

Each answer belongs to Alloy on the date shown. The full record includes the source pages behind these checks.

What changed

Formularies change on January 1

  1. sc April 1, 2026

    South Carolina

    South Carolina announced the end of weight-loss coverage for January 1, 2026, but its own list did not change on that date. The January 1, 2026 edition still shows a weight management agents class with Wegovy preferred. The class first disappears in the April 1, 2026 edition, and no February or March edition was published.

    Awaiting formulary re-read
  2. pa January 1, 2026

    Pennsylvania

    Pennsylvania ended coverage of GLP-1s for overweight and obesity on January 1, 2026, and added the class to the statewide preferred drug list. Obesity treatments that are not GLP-1s stay covered.

    Awaiting formulary re-read
  3. nc December 12, 2025

    North Carolina

    North Carolina stopped covering GLP-1s for obesity on October 1, 2025 and reinstated coverage on December 12, 2025, back to the criteria that applied on September 30, 2025.

    Awaiting formulary re-read

Approved is not the same as available

The loudest compounds online are the ones the FDA has not approved. We cover them, because the question is real and almost everything else answering it is selling something. We do it as reference only: what the agency has actually decided, and what is still pending. No protocols, no vendors, no links.

Reconstitution calculator

Convert a vial strength and the water added into the mark on your syringe. Arithmetic only. It does not know what you were prescribed and it will never suggest a dose.

Open the calculator